Defunct Company
Total Trials
9
As Lead Sponsor
2
As Collaborator
7
Total Enrollment
946
NCT02024165
Electrode-Based Sensor for Non-Invasive Fetal Heart Rate Monitoring With Improved Reliability
Phase: N/A
Role: Lead Sponsor
Start: Nov 30, 2013
Completion: Apr 30, 2014
NCT02141763
Multiple Dose Study of UCB4940 in Subjects With Psoriatic Arthritis
Phase: Phase 1
Role: Collaborator
Start: May 31, 2014
Completion: Aug 31, 2015
NCT02585700
A Study of a Seasonal Trivalent Split, Inactivated Influenza Vaccine
Start: Nov 30, 2015
Completion: Mar 31, 2016
NCT03244865
Refinement of the OBMedical LaborView System
Start: Sep 29, 2016
Completion: Apr 11, 2018
NCT02935192
Phase 3 Trial of Serbian Seasonal Influenza Vaccine
Phase: Phase 3
Start: Nov 28, 2016
Completion: Mar 25, 2017
NCT04077671
CHF6467 SAD and MAD in Patients With Diabetic Foot Ulcer
Phase: Phase 1/2
Start: Oct 17, 2018
Completion: Jan 7, 2021
NCT05009680
A Single and Repeat Dose Trial in Participants With Hepatic Impairment
Start: Sep 9, 2021
Completion: Jul 4, 2023
NCT05355571
The Impact of Probiotic Supplementation on Antibiotic Induced Changes in Gastrointestinal Function And/or Faecal Microbiota Composition
Start: Nov 18, 2022
Completion: Jan 30, 2023
NCT06507111
The Impact of Probiotics on Well-being in Women
Start: Jul 30, 2024
Completion: Feb 5, 2025